Christopher Trotta
Company: PTC Therapeutics
Job title: Senior Vice President of Discovery Biology
Seminars:
Opening Remarks 8:45 am
• Highlight past and ongoing efforts to develop RNA-targeted therapeutics • Explore the history and advancement of splicing modifiers as the cornerstone in RNA-targeted discovery • Provide a meeting roadmap, showcasing the exciting science that stems from foundational clinical successes in RNA-targeted therapeutic developmentRead more
day: Conference Day One